Clinical Trials Logo

Clinical Trial Summary

Investigation of the efficacy of a gamified augmented reality exposure app in individual with fear of spiders.


Clinical Trial Description

The study will be conducted as a randomized controlled between subject trial. The study consists of two visits and a home training for one group. 60 participants between 18 and 40 years with clinical or subclinical fear of spiders will take part in the study.

All assessments of outcome will be conducted on one visit for each participant, including an in vivo BAT. The experimental group will participate in a home training with the app, spanning over two weeks (6x30-minutes sessions), whereas the control group will not receive any treatment (untreated comparison group).

Six weeks after the first visit all participants undergo the assessments of outcome, including a second in vivo BAT. The BAT will take place 4 weeks after completion of the home training. This design allows a direct comparison and therefore an estimation of the efficacy of the gamified AR exposure therapy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04162509
Study type Interventional
Source University of Basel
Contact
Status Completed
Phase N/A
Start date October 7, 2019
Completion date December 4, 2019

See also
  Status Clinical Trial Phase
Completed NCT03907345 - Generalized Fear Extinction to Untreated Fear Stimuli in Specific Phobias After Exposure N/A
Recruiting NCT05168592 - The Neural Mechanisms of Imaginal Extinction N/A
Recruiting NCT05193383 - Neural Mechanisms of Imaginal and in Vivo Exposure N/A